Organogenesis (ORGO) Reports Q1 Loss, Lags Revenue Estimates

Organogenesis (ORGO) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of$ 0.04. This compares to loss of $0.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -425%. A quarter ago, it was expected that this regenerative medicine company would post a loss of$ 0.03 per share when it actually produced earnings of $0.04, delivering a surprise of 233.33%.Over the last four quarters, the company ...